Organon & Co.

Organon & Co. is a pharmaceutical company focused on improving the lives of women and advancing public health worldwide. It was spun off from Merck & Co., Inc. to standalone in the market, emphasizing women's health, biosimilars, and established brands. The company aims to address healthcare needs through a diverse product portfolio, delivering prescription medicines and healthcare services in areas such as fertility, contraception, menopause, and more. With operations in over 140 countries, Organon leverages its global scale to make healthcare more accessible. Headquartered in Jersey City, New Jersey, Organon & Co. plays a crucial role in the pharmaceutical industry, focusing on empowering women's health and expanding its innovations across various therapeutic areas.